Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer
Dewei Jiang, Ting Qiu, Junjiang Peng, et al.
Cell Death and Differentiation (2022) Vol. 29, Iss. 6, pp. 1283-1295
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Extracellular vesicle–packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models
Shangyou Zheng, Chengyuan Hu, Qing Lin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 756
Closed Access | Times Cited: 17
circNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1
Shuang Chen, Ke Li, Jiawei Guo, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 13
Open Access | Times Cited: 41
Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential
Ngoc Thi Minh Dinh, Tuan Minh Nguyen, Mi Kyung Park, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 717-717
Open Access | Times Cited: 13
DMT1-dependent endosome-mitochondria interactions regulate mitochondrial iron translocation and metastatic outgrowth
Jonathan Barra, Isaiah Crosbourne, Cassandra L. Roberge, et al.
Oncogene (2024) Vol. 43, Iss. 9, pp. 650-667
Open Access | Times Cited: 12
NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m5C methylation
Xuran Zhang, Ke An, Xin Ge, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 12
Positive Feedback Regulation between KLF5 and XPO1 Promotes Cell Cycle Progression of Basal like Breast Cancer
Yu Tang, Rui Liu, Jing Zhu, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Targeting YBX1‐m5C mediates RNF115 mRNA circularisation and translation to enhance vulnerability of ferroptosis in hepatocellular carcinoma
Ouwen Li, Ke An, Han Wang, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy
Qiyan Yin, Min Zheng, Qianmei Luo, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1217-1217
Open Access | Times Cited: 36
KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8+ T-cell-dependent antitumor immunity
Qi Wu, Zhou Liu, Zhijie Gao, et al.
Theranostics (2023) Vol. 13, Iss. 4, pp. 1381-1400
Open Access | Times Cited: 20
Epigenetic oncogenesis, biomarkers and emerging chemotherapeutics for breast cancer
Yusuf Oloruntoyin Ayipo, Abdulfatai Temitope Ajiboye, Wahab Adesina Osunniran, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2022) Vol. 1865, Iss. 7, pp. 194873-194873
Closed Access | Times Cited: 20
Hsa_circ_0007990 promotes breast cancer growth via inhibiting YBX1 protein degradation to activate E2F1 transcription
Tao Xu, Mengqiu Xiong, Qiwei Hong, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 4
HCP5 Derived Novel Microprotein Triggers Progression of Gastric Cancer through Regulating Ferroptosis
Qiuhui Li, Guoqing Guo, Yuli Chen, et al.
Advanced Science (2024)
Open Access | Times Cited: 4
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data
Ashley N. Spirrison, Deborah A. Lannigan
Expert Opinion on Therapeutic Targets (2024), pp. 1-13
Open Access | Times Cited: 4
KAT7-acetylated YBX1 promotes hepatocellular carcinoma proliferation by reprogramming nucleotide metabolism
He Huang, Longfei Ren, Yongqiang Zhou, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Cancer chemoprevention: signaling pathways and strategic approaches
Junling Ren, Guangli Yan, Le Yang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
HuMSCs-derived exosomal YBX1 participates in oxidative damage repair in granulosa cells by stabilizing COX5B mRNA in an m5C-dependent manner
Xiaolan Zhu, Man Lu, Wenxin Li, et al.
International Journal of Biological Macromolecules (2025), pp. 143288-143288
Closed Access
An ATP “Synthase” Derived from a Single Structural Domain of Bacterial Histidine Kinase
Shixia Ji, Yuan Zhou, Jiawen Chen, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 13
Closed Access | Times Cited: 3
Exosomal YB-1 facilitates ovarian restoration by MALAT1/miR-211-5p/FOXO3 axis
Mengxue Zhang, Jie Xing, Shijie Zhao, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 3
A primary luminal/HER2 negative breast cancer patient with mismatch repair deficiency
Xue Yang, Artem Smirnov, Oreste Claudio Buonomo, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 8
Single‐cell transcriptomics dissects epithelial heterogeneity in HPV+ cervical adenocarcinoma
Cong Wang, Lei Li, Fuhao Wang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Closed Access | Times Cited: 7
Transcription factor E2F8 is a therapeutic target in the basal-like subtype of breast cancer
Jing Zheng, Jingyi Huang, Jinquan Xia, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
A BRCA2 germline mutation and high expression of immune checkpoints in a TNBC patient
Yuyi Han, Valentina Rovella, Artem Smirnov, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
MiR‐375 impairs breast cancer cell stemness by targeting the KLF5/G6PD signaling axis
Haitao Chen, Shanshan Hou, Hongwei Zhang, et al.
Environmental Toxicology (2024)
Closed Access | Times Cited: 2
Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes
Martin Steinhoff, Majid Alam, Aamir Ahmad, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 98-116
Open Access | Times Cited: 10
The Key Role of RNA Modification in Breast Cancer
Yang Liu, Tong Zhu, Yi Jiang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top